Filed under: Drug, All Cancers
It's never a good thing when a drugmaker sends letters to doctors saying that a drug they are prescribing has resulted in confirmed deaths.
But that is what Cephalon did this week, as it admitted its cancer drug -- Fentora - has been linked to some patient deaths. Fentora, used to treat acute cancer pain, are sometimes prescribed for other pain-related ailments.
Cephalon took issue with the apparent claim that it markets Fentora for uses other than cancer pain, even though some doctors use it "off label" in normal practice.
